Ting Li
Director/Board Member at SHOUYAO HOLDINGS (BEIJING) CO., LTD.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Feng Li | M | 52 |
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 13 years |
| Bo Yan Zhang | M | 59 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 11 years |
| Ying Li Zhang | F | 40 | 8 years | |
| Lei Bi | M | 48 | 11 years | |
| Qiang Zhang | M | 66 | 4 years | |
| Wen Qi Hu | M | 62 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 7 years |
| Ke Qiang Li | M | 61 | 5 years | |
| Tian Wang | M | 33 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 5 years |
| Wen Jun Li | M | 57 | 8 years | |
| Xiao Chuan Wang | M | 46 | 3 years | |
| Jing Han Wang | M | 35 | 4 years | |
| Jia Wen Li | M | - |
Tus Cloud Control (Beijing) Technology Ltd.
 Tus Cloud Control (Beijing) Technology Ltd. Packaged SoftwareTechnology Services Tus Cloud Control (Beijing) Technology Ltd. engages in the research and development as well as the operation of cloud control basic platform for intelligent networked vehicles. It provides various industry chain users with integrated solutions to meet the needs of future intelligent networked driving, including standardized basic data and communication services, high-precision positioning services, high-precision map services, and other intelligent networked driving infrastructure services. It also provides intelligent networked driving collaborative perception, decision-making, and control function services, standardized application development environment and development platform, application simulation and test system, and other basic capability services. The company was founded on October 26, 2017 and is headquartered in Beijing, China. | - |
| Ya Jie Wang | F | 54 | 7 years | |
| Xi Jie Liu | M | 48 | 8 years | |
| Ying Hui Sun | M | 44 | 14 years | |
| Zheng Jiang Gao | M | - |
Avimetal Powder Metallurgy Technology Co., Ltd.
 Avimetal Powder Metallurgy Technology Co., Ltd. Metal FabricationProducer Manufacturing Avimetal Powder Metallurgy Technology Co., Ltd. is a Chinese company that specializes in manufacturing powder metallurgy materials and selling metal products. The company is based in Beijing, China. The company also provides 3D printing technology development, technical services, and technology consulting. The company was founded in 2015 by Zheng Jiang Gao, who has been the CEO since 2015. | 9 years |
| Xi Chen | M | 34 | 5 years | |
| Guo Jie Yang | M | 53 | 1 years | |
| Peng Cheng | M | 48 | 10 years | |
| Xiao Ming Jiang | M | 44 | 19 years | |
| Yiu Leung Cheung | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 3 years |
| Qing Xin Meng | F | 50 | 7 years | |
| Tao Zhu | M | 51 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 years |
| Xue Liu | M | 62 | 3 years | |
| Ren Yu Li | M | 63 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 years |
| Ilan Kremer | M | 57 |
University of Warwick
| 12 years |
| Yu Li Zhang | M | 59 |
Nankai University
| 16 years |
| Hai li Wang | M | - |
Hercules Microelectronics Co., Ltd.
 Hercules Microelectronics Co., Ltd. SemiconductorsElectronic Technology Hercules Microelectronics Co., Ltd. develops micro-power FPGA chips and software technology. The company is based in Beijing, China. The CEO of the Chinese company is Hai li Wang. | - |
| Zhi hua Liu | M | 44 | 1 years | |
| Jing Can Wang | F | 41 | 3 years | |
| Chun Shen Hao | M | 57 | 2 years | |
| Qi Li | M | 44 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 3 years |
| Peng Du | M | 49 |
Tus Cloud Control (Beijing) Technology Ltd.
Tus Cloud Control (Beijing) Technology Ltd. Packaged SoftwareTechnology Services Tus Cloud Control (Beijing) Technology Ltd. engages in the research and development as well as the operation of cloud control basic platform for intelligent networked vehicles. It provides various industry chain users with integrated solutions to meet the needs of future intelligent networked driving, including standardized basic data and communication services, high-precision positioning services, high-precision map services, and other intelligent networked driving infrastructure services. It also provides intelligent networked driving collaborative perception, decision-making, and control function services, standardized application development environment and development platform, application simulation and test system, and other basic capability services. The company was founded on October 26, 2017 and is headquartered in Beijing, China. | - |
| Tong Li | F | 49 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 7 years |
| Shuang Liu | M | 35 | 4 years | |
| Fang Qin | F | - | - | |
| Zheng Shi | M | - |
Tus Cloud Control (Beijing) Technology Ltd.
Tus Cloud Control (Beijing) Technology Ltd. Packaged SoftwareTechnology Services Tus Cloud Control (Beijing) Technology Ltd. engages in the research and development as well as the operation of cloud control basic platform for intelligent networked vehicles. It provides various industry chain users with integrated solutions to meet the needs of future intelligent networked driving, including standardized basic data and communication services, high-precision positioning services, high-precision map services, and other intelligent networked driving infrastructure services. It also provides intelligent networked driving collaborative perception, decision-making, and control function services, standardized application development environment and development platform, application simulation and test system, and other basic capability services. The company was founded on October 26, 2017 and is headquartered in Beijing, China. | - |
| Xin He Xu | M | 50 | 5 years | |
| Wing Sze Yu | F | 41 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| Yan Qi | F | 54 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 17 years |
| Pei Ye | F | 61 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 years |
| Hui Fang Liu | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 years |
| Jin Jin Liang | M | 55 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 5 years |
| Jing Zhang | F | 42 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 11 years |
| Bo Hu | M | 51 |
Tus Cloud Control (Beijing) Technology Ltd.
Tus Cloud Control (Beijing) Technology Ltd. Packaged SoftwareTechnology Services Tus Cloud Control (Beijing) Technology Ltd. engages in the research and development as well as the operation of cloud control basic platform for intelligent networked vehicles. It provides various industry chain users with integrated solutions to meet the needs of future intelligent networked driving, including standardized basic data and communication services, high-precision positioning services, high-precision map services, and other intelligent networked driving infrastructure services. It also provides intelligent networked driving collaborative perception, decision-making, and control function services, standardized application development environment and development platform, application simulation and test system, and other basic capability services. The company was founded on October 26, 2017 and is headquartered in Beijing, China. | - |
| Zhan Chao Liang | M | 40 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shu Pei Li | M | 43 |
Nankai University
| 4 years |
| Qing Bin Meng | M | 44 |
Nankai University
| 4 years |
| Wen Feng Shi | M | 46 |
Nankai University
| 4 years |
| Xin Qu | F | 61 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| Pui Ho Li | M | 34 |
University of Warwick
| 5 years |
| Min Wang | M | 40 |
Nankai University
| 6 years |
| Ted Jing | M | - |
Nankai University
| 4 years |
| Lauren Baker Iguaz | F | - |
University of Warwick
| 4 years |
| Li Guan | M | 47 |
Nankai University
| 2 years |
| Yuxi Xiong | M | 33 |
University of Warwick
| 1 years |
| Ting Ting Zhang | F | 33 |
Nankai University
| 3 years |
| Gunita Bhasin | F | - |
University of Warwick
| 3 years |
| Olivia Lingyun Zhang | F | - |
Nankai University
| 4 years |
| Chunzheng Song | M | 47 |
Nankai University
| 2 years |
| Gerardo Martinez | M | - |
University of Warwick
| 4 years |
| Jin-Huei Ding | M | 65 |
Nankai University
| 3 years |
| Prashanth Palepu | M | 31 |
University of Warwick
| 2 years |
| Zhao Ning Li | M | 46 |
Nankai University
| 1 years |
| Sarah Mamo | M | - |
University of Warwick
| 2 years |
| Le Nguyen Thuy | F | - |
University of Warwick
| 3 years |
| Daniel Edwards | M | - |
University of Warwick
| 4 years |
| Dai Ping Chen | M | 41 |
Nankai University
| 4 years |
| Xu Zhao | M | 38 |
Nankai University
| 4 years |
| Jaivir Pall | M | - |
University of Warwick
| 3 years |
| Lu Yu | M | 62 |
Nankai University
| 2 years |
| Vanessa Santhakumar | F | 34 |
University of Warwick
| 1 years |
| Ajay Johal | M | - |
University of Warwick
| 4 years |
| Sheel Shah | M | - |
University of Warwick
| 3 years |
| Oliver Ronald Bramwell | M | 43 |
University of Warwick
| 1 years |
| Xue Qing Hu | M | 53 |
Nankai University
| 1 years |
| Aneri D. Patel | F | 33 |
University of Warwick
| 3 years |
| Gabriel Danielachvili | M | - |
University of Warwick
| 3 years |
| Xiao Xuan Li | M | 50 |
Nankai University
| 2 years |
| Tulsi Gupta | F | 32 |
University of Warwick
| 3 years |
| Ming Zhou Fan | M | 45 |
Nankai University
| 3 years |
| Shivani Rajani | F | - |
University of Warwick
| 3 years |
| Ping Yan Bai | M | 52 |
Nankai University
| 2 years |
| Elia Videtta | M | - |
University of Warwick
| 4 years |
| Pei Yang Guo | M | 35 |
University of Warwick
| 1 years |
| Kishan Chotai | M | 34 |
University of Warwick
| 3 years |
| Shuang Liang | F | 35 |
University of Warwick
| 1 years |
| Xiao Hui Zhu | F | 29 |
University of Warwick
| 4 years |
| Zhi Yuan Zhou | M | 36 |
Nankai University
| 3 years |
| Yang Li | F | 32 |
University of Warwick
| 3 years |
| Edwin Kwok | M | - |
University of Warwick
| 4 years |
| Da Cheng | M | 47 |
Nankai University
| 4 years |
| Omar Al-Busaidi | M | - |
University of Warwick
| 4 years |
| Rong Sheng Li | M | 36 |
Nankai University
| - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 67 | 71.28% |
| United Kingdom | 27 | 28.72% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ting Li
- Personal Network
